Trending News
News
News
Brain Stem Cells Sensitive to Space Radiation
Measures to protect astronauts from health risks caused by space radiation will be important during extended missions to the moon or Mars, say researchers.
News
EMD Partners with Rules-Based Medicine to Develop and Distribute Multi-Analyte Kits
Under the terms of the agreement, RBM is granting EMD/Merck exclusive distribution rights to the largest catalog of quantitative protein multiplex assays currently available.
News
Discovery of Novel Anti-tumor Antimitotic Agents That Also Reverse Tumor Resistance
Scientists at Duquesne University and the Medical University of South Carolina report in the on line version of the Journal of Medicinal Chemistry (50, 3290, 2007) on novel compounds with potent anti-tumor activity, which are also active on cancer cells resistant to other anti-tumor agents.
News
CEMMNT Expands to Accelerate Industry Innovation
The Smith & Nephew Technical Services Group (TSG) and CEMMNT have partnered to deliver measurement, characterization and analytical solutions for industry.
News
Duke Researchers Discover Virus Using Same Tools as Host Cell
The virus which causes Kaposi's sarcoma encodes a molecule for controlling gene regulation nearly identical to one found normally in human cells.
News
BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology
Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
News
University of Ottawa Heart Institute Uses Affymetrix SNP Array 6.0 to Replicate Whole-genome Association Study Findings
Researchers at the cardiovascular center are screening 12,000 individuals to identify and develop treatments for the causes of coronary artery disease.
News
Inovio Biomedical Receives Additional Milestone Payment from Merck Relating to Electroporation Delivery System for DNA Vaccines
Inovio will receive $2 million resulting from the filing of a second IND application to the US FDA by Merck for a DNA- vaccine using Inovio's DNA delivery system.
News
Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
An IND has been filed with the FDA for the fourth Genmab antibody developed under the company's collaboration with Roche.
News
ChemGenex Investigators Report Omacetaxine Effective in Killing CML Stem Cells in Animal Model Studies
Study demonstrates that omacetaxine had a direct anticancer effect on leukemic stem cells that was not exhibited by the tyrosine kinase inhibitor imatinib.
Advertisement